|
|
amine metabolic process
|
GO:0009308 |
45 |
0.210
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.162
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.154
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.139
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.139
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.119
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.116
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.102
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.102
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.097
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.093
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.093
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.093
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.086
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.082
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.079
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.077
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.077
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.077
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.075
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.075
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.075
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.072
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.071
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.070
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.067
|
|
|
|
positive regulation of transforming growth factor beta secretion
|
GO:2001203 |
1 |
0.066
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.063
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.062
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.062
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.061
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.061
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.060
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.058
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.057
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.057
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.057
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.056
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.056
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.055
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.054
|
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
4 |
0.054
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.054
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.053
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.052
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.051
|
|
|
|
negative regulation of myoblast differentiation
|
GO:0045662 |
18 |
0.051
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.051
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.050
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.050
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.049
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.049
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.049
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.048
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.048
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.047
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.046
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.046
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.046
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.045
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.045
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.045
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.045
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.045
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.045
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.045
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.044
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.044
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.044
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.044
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.044
|
|
|
|
transforming growth factor beta secretion
|
GO:0038044 |
1 |
0.043
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.043
|
|
|
|
regulation of transforming growth factor beta secretion
|
GO:2001201 |
1 |
0.043
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.042
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.042
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.042
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.042
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.042
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.041
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.041
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.041
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.041
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.040
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.040
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.040
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.040
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.039
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.039
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.039
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.039
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.038
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.038
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.038
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.038
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.038
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.038
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.038
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.037
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.037
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.037
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.037
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.037
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.037
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.037
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.036
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.036
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.035
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.035
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.035
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.035
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.035
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.035
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.034
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.034
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.034
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.034
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.033
|
|
|
|
negative regulation of muscle cell differentiation
|
GO:0051148 |
33 |
0.033
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.033
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.032
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.032
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.032
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.032
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.032
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.032
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.032
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.031
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.031
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.031
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.031
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.031
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.031
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.031
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.030
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.030
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.030
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.030
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.030
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.030
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.030
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.030
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.030
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.030
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.030
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.029
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.029
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.029
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.029
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.028
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.028
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.028
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.028
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.028
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.028
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.028
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.028
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.028
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.027
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.027
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.027
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.027
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.027
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.027
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.027
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.027
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.027
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.026
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.026
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.026
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.026
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.026
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.026
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.026
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.026
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.026
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.025
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.025
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.025
|
|
|
|
learning
|
GO:0007612 |
98 |
0.025
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.025
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.025
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.025
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.025
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.024
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.024
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.024
|
|
|
|
stimulatory c type lectin receptor signaling pathway
|
GO:0002223 |
2 |
0.024
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.024
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.024
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.024
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.024
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.024
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.024
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.024
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.024
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.023
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.023
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.023
|
|
|
|
negative regulation of interleukin 13 production
|
GO:0032696 |
2 |
0.023
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.023
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.023
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.023
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.023
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.023
|
|
|
|
regulation of brown fat cell proliferation
|
GO:0070347 |
1 |
0.023
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.023
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.023
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.023
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.023
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.023
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.023
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.022
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.022
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.022
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.022
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.022
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.022
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.022
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.022
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.022
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.022
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.022
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.022
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.022
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.022
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.022
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.021
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.021
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.021
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.021
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.021
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.021
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.021
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.021
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.021
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.021
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.021
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.021
|
|
|
|
neutrophil mediated killing of gram positive bacterium
|
GO:0070946 |
2 |
0.021
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.021
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.021
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.021
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.021
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.021
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.021
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.021
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.020
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.020
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.020
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.020
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.020
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.020
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.020
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.020
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.020
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.020
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.020
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.020
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.020
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.020
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.020
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.020
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.019
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.019
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.019
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.019
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.019
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.019
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.019
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.019
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.019
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.019
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.019
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.019
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.019
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.019
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.019
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.019
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.019
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.019
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.019
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.019
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.019
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.018
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.018
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.018
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.018
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.018
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.018
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.018
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.018
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.018
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.018
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.018
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.018
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.018
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.018
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.018
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.018
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.018
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.018
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.018
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.018
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.018
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.018
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.018
|
|
|
|
regulation of t cell mediated immunity
|
GO:0002709 |
34 |
0.018
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.018
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.017
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.017
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.017
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.017
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.017
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.017
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.017
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.017
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.017
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.017
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.017
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.017
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.017
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.017
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.017
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.017
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.017
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.017
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.017
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.017
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.017
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.017
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.017
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.017
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.017
|
|
|
|
negative regulation of oxidative phosphorylation uncoupler activity
|
GO:2000276 |
2 |
0.017
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.017
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.017
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.016
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.016
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.016
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.016
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.016
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.016
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.016
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.016
|
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.016
|
|
|
|
synaptic transmission gabaergic
|
GO:0051932 |
19 |
0.016
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.016
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.016
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.016
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.016
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.016
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.016
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.016
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.016
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.016
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.016
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.016
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.016
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.016
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.016
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.016
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.016
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.016
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.016
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.015
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.015
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.015
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.015
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.015
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.015
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.015
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.015
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.015
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.015
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.015
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.015
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.015
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.015
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.015
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.015
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.015
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.015
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.015
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.015
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.015
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.015
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.015
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.015
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.015
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.015
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.015
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.015
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.015
|
|
|
|
positive regulation of semaphorin plexin signaling pathway
|
GO:2001262 |
1 |
0.015
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.015
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.015
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.015
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.015
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.014
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.014
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.014
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.014
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.014
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.014
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.014
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.014
|
|
|
|
negative regulation of type b pancreatic cell apoptotic process
|
GO:2000675 |
3 |
0.014
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.014
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.014
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.014
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.014
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.014
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.014
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.014
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.014
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.014
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.014
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.014
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.014
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.014
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.014
|
|
|
|
negative regulation of t cell cytokine production
|
GO:0002725 |
1 |
0.014
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.014
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.014
|
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.014
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.014
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.014
|
|
|
|
interleukin 5 secretion
|
GO:0072603 |
2 |
0.013
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.013
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.013
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.013
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.013
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.013
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.013
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.013
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.013
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.013
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.013
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.013
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.013
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.013
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.013
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.013
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.013
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.013
|
|
|
|
regulation of interleukin 5 secretion
|
GO:2000662 |
2 |
0.013
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.013
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.013
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.013
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.013
|
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.013
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
31 |
0.013
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.013
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.013
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.013
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.013
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.013
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.013
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.013
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.013
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.013
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.012
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.012
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.012
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.012
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.012
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.012
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.012
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.012
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.012
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.012
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.012
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.012
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.012
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.012
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.012
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.012
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.012
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.012
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.012
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.012
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.012
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.012
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.012
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.012
|
|
|
|
chloride transport
|
GO:0006821 |
32 |
0.012
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.012
|
|
|
|
response to molecule of fungal origin
|
GO:0002238 |
4 |
0.012
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.012
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.012
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.012
|
|
